Table 2 Demographic and clinical characteristics of 317 patients with pulmonary tuberculosis (TB) included in the analysis
From: Non-hispanic whites have higher risk for pulmonary impairment from pulmonary tuberculosis
| Â | Non-Hispanic White | Non-Hispanic Black | Asian | Hispanic | Â |
|---|---|---|---|---|---|
| Â | n = 69 | n = 85 | n = 82 | n = 81 | p-value |
Demography | |||||
Male | 58 (84) | 54 (64) | 58 (71) | 52 (64) | 0.023 |
US-born | 66 (96) | 62 (73) | 4 (5) | 11 (4) | < 0.001 |
Foreign-born | 3 (4) | 23 (27) | 78 (95) | 70 (86) | Â |
Age (mean[SD]) years | 54.33 (13.10) | 43.71 (13.51) | 44.91 (16.61) | 45.95 (15.81) | < 0.001 |
Clinical | |||||
HIV positive | 5 (7) | 15 (18) | 3 (4) | 7 (9) | 0.052 |
Ever-Smokers n(%) | 56 (81) | 44 (52) | 35 (43) | 39 (48) | < 0.001 |
Smoking volume(mean[SD]) pack-years | 32.68 (39.56) | 8.19 (15.48) | 5.52 (9.50) | 4.67 (11.78) | < 0.001 |
Biomass Smoke | Â | Â | Â | Â | Â |
Exposed n (%) | 5 (9) | 10 (15) | 29 (45) | 28 (38) | 0.001 |
Biomass Smoke Exposure duration | Â | Â | Â | Â | Â |
(mean [SD]) years | 0.80 (3.26) | 2.52 (7.38) | 6.94 (12.54) | 7.09 (14.27) | 0.001 |
FVC (% predicted [SD]) | 77.54 (23.70) | 78.69 (19.05) | 82.09 (19.10) | 90.15 (21.19) | 0.001 |
FEV1 (% predicted[SD]) | 71.12 (24.30) | 76.98 (22.69) | 82.85 (19.54) | 91.83 (23.03) | < 0.001 |
FEV1/FVC (% [SD]) | 73.13 (13.48) | 81.11 (13.35) | 84.01 (9.75) | 85.26 (10.01) | < 0.001 |
BMI (mean[SD]) | 21.23 (5.24) | 23.07 (4.58) | 22.32 (4.90) | 25.08 (8.62) | < 0.001 |
Disease site and pattern | |||||
PTB only | 66 (96) | 75 (88) | 76 (93) | 75 (93) | 0.39 |
PTB and EPTB | 3 (4) | 10 (12) | 6 (7) | 6 (7) | Â |
Pattern of Impairment | |||||
   Restrictive | 33 (68) | 34 (69) | 30 (75) | 21 (81) | 0.571 |
   Obstructive | 8 (16) | 4 (8) | 3 (8) | 3 (11) |  |
   Mixed | 8 (16) | 11 (23) | 7 (17) | 2 (8) |  |
Access (median [IQR]) Days to Begin TB Treatment | 63 (183) | 65 (130) | 93 (157) | 80 (103) | 0.978 |